IT201700117361A1 - Composizione liquida per uso come antiinfiammatorio - Google Patents

Composizione liquida per uso come antiinfiammatorio

Info

Publication number
IT201700117361A1
IT201700117361A1 IT102017000117361A IT201700117361A IT201700117361A1 IT 201700117361 A1 IT201700117361 A1 IT 201700117361A1 IT 102017000117361 A IT102017000117361 A IT 102017000117361A IT 201700117361 A IT201700117361 A IT 201700117361A IT 201700117361 A1 IT201700117361 A1 IT 201700117361A1
Authority
IT
Italy
Prior art keywords
inflammatory
liquid composition
composition
liquid
Prior art date
Application number
IT102017000117361A
Other languages
English (en)
Inventor
Alessio Ferrari
Original Assignee
Alfakjn S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfakjn S R L filed Critical Alfakjn S R L
Priority to IT102017000117361A priority Critical patent/IT201700117361A1/it
Priority to EP18803474.8A priority patent/EP3697444B1/en
Priority to EA202090788A priority patent/EA202090788A1/ru
Priority to PCT/IB2018/058051 priority patent/WO2019077521A1/en
Publication of IT201700117361A1 publication Critical patent/IT201700117361A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT102017000117361A 2017-10-17 2017-10-17 Composizione liquida per uso come antiinfiammatorio IT201700117361A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT102017000117361A IT201700117361A1 (it) 2017-10-17 2017-10-17 Composizione liquida per uso come antiinfiammatorio
EP18803474.8A EP3697444B1 (en) 2017-10-17 2018-10-17 Liquid composition for use and as an anti-inflammatory
EA202090788A EA202090788A1 (ru) 2017-10-17 2018-10-17 Жидкая композиция для использования в качестве противовоспалительного средства
PCT/IB2018/058051 WO2019077521A1 (en) 2017-10-17 2018-10-17 LIQUID COMPOSITION FOR USE AS ANTI-INFLAMMATORY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000117361A IT201700117361A1 (it) 2017-10-17 2017-10-17 Composizione liquida per uso come antiinfiammatorio

Publications (1)

Publication Number Publication Date
IT201700117361A1 true IT201700117361A1 (it) 2019-04-17

Family

ID=61187724

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000117361A IT201700117361A1 (it) 2017-10-17 2017-10-17 Composizione liquida per uso come antiinfiammatorio

Country Status (4)

Country Link
EP (1) EP3697444B1 (it)
EA (1) EA202090788A1 (it)
IT (1) IT201700117361A1 (it)
WO (1) WO2019077521A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000003733A1 (it) * 2020-02-24 2021-08-24 Terminter S R L Diluizione colloidale per uso topico ed orale
IT202000025963A1 (it) * 2020-11-02 2022-05-02 Neilos S R L “composizione per la prevenzione e il trattamento di affezioni dell’apparato respiratorio”

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017025903A1 (en) * 2015-08-13 2017-02-16 Alfakjn S.R.L. Injectable liquid composition for use in the intra-articular infiltration therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005293A1 (en) * 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
ITMI20030195A1 (it) * 2003-02-06 2004-08-07 Bsd Bioscience Dev Snc Di O Mini C E Zucc Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
TWI466675B (zh) * 2011-09-16 2015-01-01 Univ China Medical 用於抑制發炎之醫藥組合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017025903A1 (en) * 2015-08-13 2017-02-16 Alfakjn S.R.L. Injectable liquid composition for use in the intra-articular infiltration therapy

Also Published As

Publication number Publication date
EP3697444A1 (en) 2020-08-26
EA202090788A1 (ru) 2020-06-15
WO2019077521A1 (en) 2019-04-25
EP3697444B1 (en) 2022-03-09

Similar Documents

Publication Publication Date Title
ES2796903T8 (es) Procedimiento de uso de inmunoconjugados anti-CD79b
BR112017020358A2 (pt) composição farmacêutica de tetraciclina para uso dermatológico
DOP2015000219A (es) Compuestos de heteroarilo y sus usos
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
DK3558278T3 (da) Flydende cannabinoidsammensætning
DK3532029T3 (da) Flydende farmaceutisk sammensætning
CL2016001313A1 (es) Formulaciones listas de fertilizante líquido de bifentrina.
BR112016026046A2 (pt) Uso de compostos de tienotriazolodiazepina
EP3261676A4 (en) Liquid levothyroxine formulations
ZA201907313B (en) Stable liquid pharmaceutical composition
DK3278801T3 (da) Farmaceutisk sammensætning indeholdende mirabegron
BR112017002090A2 (pt) formulação de fator viii
EP3395325A4 (en) LIQUID COSMETIC COMPOSITION
CL2014001862A1 (es) Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.
EP3569224A4 (en) STABLE LIQUID FORMULA
LT3419595T (lt) Stabili skysta gonadotropino kompozicija
DK3397734T3 (da) Brændstofsammensætning
BR112015021722A2 (pt) composição para uso no tratamento de síndrome do ovário policístico
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
IT201700117361A1 (it) Composizione liquida per uso come antiinfiammatorio
ES1209313Y (es) Composicion liofilizada
DK3255550T3 (da) TLB shootdowns til lave omkostninger
FR3024150B1 (fr) Formulation pour lame de balai d'essuie-glace
IT201700006360A1 (it) Composizione per uso oftalmico
IT201700040834A1 (it) Composizioni comprendenti oli essenziali per uso topico